Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 9,698 | 8,466 | 7,470 | 30,067 | 14,269 |
| Gross Profit | 9,698 | 8,466 | 7,470 | 30,067 | 14,269 |
| Operating Expenses | 136,509 | 128,617 | 126,756 | 130,104 | 120,773 |
| Operating Income | -126,811 | -120,151 | -119,286 | -100,037 | -106,504 |
| Other Income | 14,083 | 17,860 | 10,016 | 9,683 | 9,836 |
| Pre-tax Income | -112,728 | -102,291 | -109,270 | -90,354 | -96,668 |
| Net Income Continuous | -112,728 | -102,291 | -109,270 | -90,354 | -96,668 |
| Net Income | $-112,728 | $-102,291 | $-109,270 | $-90,354 | $-96,668 |
| EPS Basic Total Ops | -1.10 | -1.00 | -1.24 | -1.09 | -1.17 |
| EPS Basic Continuous Ops | -1.10 | -1.00 | -1.24 | -1.09 | -1.17 |
| EPS Diluted Total Ops | -1.10 | -1.00 | -1.24 | -1.09 | -1.17 |
| EPS Diluted Continuous Ops | -1.10 | -1.00 | -1.24 | -1.09 | -1.17 |
| EPS Diluted Before Non-Recurring Items | -1.10 | -1.00 | -1.24 | -1.09 | -1.17 |
| EBITDA(a) | $-125,484 | $-119,231 | $-117,607 | $-99,234 | $-106,652 |